ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2186

What Is an Important Difference in Gait Speed in Adults with Knee Osteoarthritis?

Jing Song 1, David Cella 2, Abigail Gilbert3, Rowland Chang 2 and Dorothy Dunlop 2, 1Northwestern University Feinberg School of Medicine, Worthington, OH, 2Northwestern University Feinberg School of Medicine, Chicago, IL, 3University of North Carolina, Chapel Hill, NC

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: gait and outcome measures, Osteoarthritis, physical function

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: Osteoarthritis – Clinical Poster II

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Little is known regarding what difference in functional performance measures are clinically significant in individuals with a chronic medical disease. This study examines the important differences in gait speed in adults with knee osteoarthritis.

Methods: Functional performance was objectively measured by gait speed using 20-meter and 400-meter walk tests among adults with radiographic knee osteoarthritis participating in the Osteoarthritis Initiative at baseline and 2 years later. Distribution-based methods were used to frame the range of gait speed likely to be considered important. We then utilized anchor-based methods using chair stand rate and self-reported physical function as anchors to calculate important gait speed differences.

Results: We included 2527 participants with radiographic knee osteoarthritis. Mean age was 62.6 years. Just over half (58%) of participants were female. Most participants were either overweight (39%) or obese (45%). Half (54%) had Kellgren Lawrence (K/L) grade 2 knee OA, 35% had K/L grade 3 knee OA and 11% had K/L grade 4 knee OA. Calculation of the distribution-based estimates resulted in a range from 4.1 to 6.4 meters/minute for 20-meter walk and 2.9 to 6.5 meters/minute for 400-meter walk. Anchor-based estimates ranged from 5.4 to 6.9 meters/minute for 20-meter walk and 3.0 to 6.9 meters/minute for 400-meter walk. Combining distribution-based and anchor-based methods we found the important gait speed difference for 20-meter walk is between 4.1 and 6.9 meters/minute and for 400-meter walk is between 2.9 and 6.9 meters/minute.

Conclusion: Our results found the important difference in gait speed for 20-meter walk and 400-meter walk are consistent with previous important difference estimates for older adult populations. These findings can provide benchmarks for assessing and understanding functional performance outcomes when comparing exposure groups and can be used in designing future studies targeting adults with knee osteoarthritis.


AGilbert.gait speed CID.ACR abstract 2019 Table

Table: Baseline characteristics


AGilbert.gait speed CID.ACR abstract 2019 figure

Figure: Summary of usable anchor-based important difference estimates


Disclosure: J. Song, None; D. Cella, AbbVie, 5, Alexion Pharmaceuticals, 5, Astellas Pharma, 5, Bayer AG, 5, Board of Directors for PROMIS Health Organization, 6, Bristol-Myers Squibb, 5, Clovis Oncology Inc, 5, Clovis Oncology Inc., 5, Evidera, 5, Exelixis Inc., 5, FACITtrans LLC (FACIT.org), 4, Functional Assessment of Chronic Illness Therapy (FACIT.org), 4, Horizon Pharma Inc., 5, Janssen Pharmaceuticals Inc, 5, Janssen Pharmaceuticals Inc., 5, Merck/Schering-Plough Pharmaceuticals, 5, National Academy of Sciences, 5, Novartis Pharma K.K. (Japan), 5, Pfizer Inc, 5, Pfizer Inc., 5, Pled Pharma, 5, PROMIS Health Organization, 6, Regeneron Pharmaceuticals Inc., 5; A. Gilbert, None; R. Chang, None; D. Dunlop, None.

To cite this abstract in AMA style:

Song J, Cella D, Gilbert A, Chang R, Dunlop D. What Is an Important Difference in Gait Speed in Adults with Knee Osteoarthritis? [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/what-is-an-important-difference-in-gait-speed-in-adults-with-knee-osteoarthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/what-is-an-important-difference-in-gait-speed-in-adults-with-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology